XRP9881 in Combination With Trastuzumab in Metastatic Breast Cancer

Clinical trial NCT00386685 · COMPLETED

Trial details

NCT number: NCT00386685
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2006-07-01
Primary completion: 2008-10-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.